Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Epithelial Tumors, Malignant
Interventions: DRUG: MT-302 (A)
Sponsor: Myeloid Therapeutics